CDKN2A and neoplasm: Recent findings implicate that PRC2 is an important driver of tumor development and progression by suppressing various key genes, such as CDH1, DKKI and INK/ARF.45 DNA-binding factors are involved the recruitment of PRC2 to specific target genes.